Pharyngeal Neoplasm - Pipeline Review, H2 2012 New Port
Pharyngeal Neoplasm - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Pharyngeal Neoplasm, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pharyngeal Neoplasm. Pharyngeal Neoplasm - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press...
View full press release